Literature DB >> 497895

Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen.

F Coceani, E White, E Bodach, P M Olley.   

Abstract

Circular strips of ductus arteriosus from lambs of gestational age between 90 and 144 days (term 147 days) were studied in vitro at low (8--16 torr (1 torr = 133.322 Pa)) and high (426--622 torr) PO2. Potassium- and oxygen-induced contractions increased with the gestational age and attained a maximum at term. At low PO2, ibuprofen, a blocker of prostaglandin synthesis, produced a dose-dependent contraction of the ductus at all ages and enhanced the potassium-induced contraction of the immature ductus (90--124 days). Both effects were relatively greater in the 103- to 107-day gestational group. At that age, ibuprofen also potentiated the oxygen-induced contraction. These findings, while confirming that a prostaglandin is involved in ductus patency, indicate that the prostaglandin-relaxing mechanism becomes functional at an early stage of gestation and reaches maximal activity before term. The existence of an active, prostaglandin-mediated relaxation in the preterm ductus may account, in part, for the reduced responsiveness of the vessel to oxygen. It is confirmed that ibuprofen and other nonsteroidal antiinflammatory drugs are well suited for the management of the premature infant with patent ductus arteriosus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 497895     DOI: 10.1139/y79-126

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  16 in total

1.  Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.

Authors:  Arne Ohlsson; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2019-06-21

2.  Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.

Authors:  Arne Ohlsson; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2020-01-27

3.  Function of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the ductus arteriosus from foetal lamb: differential development and change by oxygen and endotoxin.

Authors:  F Coceani; C Ackerley; E Seidlitz; L Kelsey
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

4.  Treatment of patent ductus arteriosus with ibuprofen.

Authors:  B Van Overmeire; I Follens; S Hartmann; W L Creten; K J Van Acker
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-05       Impact factor: 5.747

5.  Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.

Authors:  Karen E Corff; Kris C Sekar
Journal:  J Pediatr Pharmacol Ther       Date:  2007-07

6.  Common clinical and practical questions on the use of intravenous Ibuprofen lysine for the treatment of patent ductus arteriosus.

Authors:  Bart Van Overmeire
Journal:  J Pediatr Pharmacol Ther       Date:  2007-07

Review 7.  Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit.

Authors:  Palmer G Johnston; Maria Gillam-Krakauer; M Paige Fuller; Jeff Reese
Journal:  Clin Perinatol       Date:  2012-01-13       Impact factor: 3.430

8.  Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin.

Authors:  J L Grosfeld; M Chaet; F Molinari; W Engle; S A Engum; K W West; F J Rescorla; L R Scherer
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

Review 9.  Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.

Authors:  Sindhu Sivanandan; Ramesh Agarwal
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

10.  Effect of oral ibuprofen on patent ductus arteriosus in premature newborns.

Authors:  Sabry Ghanem; Mansour Mostafa; Mohamed Shafee
Journal:  J Saudi Heart Assoc       Date:  2010-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.